Optimal Duration of Anticoagulation in Cancer Patients with Isolated Distal Deep Vein Thrombosis: The ONCO DVT Trial

Optimal Duration of Anticoagulation in Cancer Patients with Isolated Distal Deep Vein Thrombosis: The ONCO DVT Trial

The ONCO DVT study showed that 12 months of edoxaban was more effective than 3 months in preventing recurrent symptomatic venous thromboembolism (VTE) or VTE-related death in cancer patients with isolated distal deep vein thrombosis (DVT). Dr. Yugo Yamashita of Kyoto University, presented during the Hot Line session of the ESC Congress, 2023. 

In the ONCO DVT study, from April 2019 to June 2022, 604 cancer patients who were newly diagnosed wi...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Learn more about TCROSS NEWS Global
This website is automatically translated using Google Translate.

Recommendations

Switching from Warfarin to DOAC in Frail Elderly Patients with Atrial Fibrillation: the FRAIL-AF Trial
Switching from Warfarin to DOAC in Frail Elderly Patients with Atrial Fibrillation: the FRAIL-AF Trial
ESC 2023
2023 ESC Guidelines: Management of Cardiomyopathies
2023 ESC Guidelines: Management of Cardiomyopathies
ESC 2023
Diagnostic and Therapeutic Guidelines for Acute and Chronic Heart Failure: ESC 2023 Focused Update
Diagnostic and Therapeutic Guidelines for Acute and Chronic Heart Failure: ESC 2023 Focused Update
ESC 2023
Aspirin-Free Antithrombotic Therapy After PCI: The STOPDAPT-3 Trial
Aspirin-Free Antithrombotic Therapy After PCI: The STOPDAPT-3 Trial
ESC 2023
PICK UP
Challenging Healthcare Marketing Costs toward Achieving Universal Health Coverage
Special
InsighTCROSS
Optimal IVUS-Guided LM-PCI: The OPTIVUS-Complex PCI Study LMCA Cohort
AJC
Optimal IVUS-Guided LM-PCI: The OPTIVUS-Complex PCI Study LMCA Cohort
Comparison of Limus and Paclitaxel Drug-Coated Balloons, Second-Generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials
Circ Intervention
Comparison of Limus and Paclitaxel Drug-Coated Balloons, Second-Generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials
Predictors of Cardiovascular Events After Coronary IVL Use: The BENELUX-IVL Registry
AJC
Predictors of Cardiovascular Events After Coronary IVL Use: The BENELUX-IVL Registry
Orbital Atherectomy vs Balloon-Based Vessel Preparation for Severely Calcified Coronary Lesions: The ECLIPSE OCT Substudy
Circ Intervention
Orbital Atherectomy vs Balloon-Based Vessel Preparation for Severely Calcified Coronary Lesions: The ECLIPSE OCT Substudy